Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Open accessThe DOI matches its Crossref record; 264 of the 275 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the clinical and cost-effectiveness of vitamin K in preventing osteoporotic fractures in postmenopausal women. DATA SOURCES: Searches were conducted in May 2007 in MEDLINE, MEDLINE In-Process, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Controlled Trials Register, BIOSIS, CINAHL, DARE, NHS EED and HTA databases, AMED, NRR, Science Citation Index and Current Controlled Trials. The MEDLINE search was updated in March 2009. REVIEW METHODS: Selected studies were assessed and subjected to data extraction and quality assessment using standard methods. Where appropriate, meta-analysis was carried out. A mathematical model was constructed to estimate the cost-effectiveness of vitamin K1. RESULTS: The electronic literature searches identified 1078 potentially relevant articles. Of these, 14 articles relating to five trials that compared vitamin K with a relevant comparator in postmenopausal women with osteoporosis or osteopenia met the review inclusion criteria. The double-blind ECKO trial compared 5 mg of phylloquinone (vitamin K1) with placebo in Canadian women with osteopenia but without osteoporosis. Four open-label trials used 45 mg of menatetrenone (vitamin K2) in Japanese women with osteoporosis; the comparators were no treatment, etidronate or calcium. The methodological quality of the ECKO trial was good; however, all four menatetrenone trials were poorly reported and three were very small (n < 100 in each group). Phylloquinone was associated with a statistically significant reduction in the risk of clinical fractures relative to placebo [relative risk 0.46, 95% confidence interval (CI) 0.22 to 0.99]; morphometric vertebral fractures were not reported. The smaller menatetrenone trials found that menatetrenone was associated with a reduced risk of morphometric vertebral fractures relative to no treatment or calcium; however, the larger Osteoporosis Fracture (OF) study found no evidence of a reduction in vertebral fracture risk. The three smaller trials found no significant difference between treatment groups in non-vertebral fracture incidence. In the ECKO trial, phylloquinone was not associated with an increase in adverse events. In the menatetrenone trials, adverse event reporting was generally poor; however, in the OF study, menatetrenone was associated with a significantly higher incidence of skin and skin appendage lesions. No published economic evaluations of vitamin K were found and a mathematical model was thus constructed to estimate the cost-effectiveness of vitamin K1. Comparators were alendronate, risedronate and strontium ranelate. Vitamin K1 and alendronate were markedly more cost-effective than either risedronate or strontium ranelate. The base-case results favoured vitamin K1, but this relied on many assumptions, particularly on the efficacy of preventing hip and vertebral fractures. Calculation of the expected value of sampled information was conducted assuming a randomised controlled trial of 5 years' duration comparing alendronate with vitamin K1. The costs incurred in obtaining updated efficacy data from a trial with 2000 women per arm were estimated to be a cost-effective use of resources. CONCLUSIONS: There is currently large uncertainty over whether vitamin K1 is more cost-effective than alendronate; further research is required. It is unlikely that the present prescribing policy (i.e. alendronate as first-line treatment) would be altered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are insufficient data for hip fracture outcomes from trials of alphacalcidiol, 26 B 12 /folate, or vitamin K by other investigators, but vitamin K is reported to have no effect on bone density 29 or vertebral fracture risk.30”
From Systematic review and statistical analysis of the integrity of 33 randomized controlled trials (2016) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
1 retracted
Ishida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 132
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Norman, A. W. (1979) · Cited by 3,769
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
(1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90218-e · Cited by 2,874
ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS
Alexeeva, L. P., Burkhardt, P., Christiansen, C., Cooper, C. C., Delmas, P. D., Johnell, O., Johnston, C. C., Kanis, J. A., Lips, P. T. A. M., Melton, L. J., et al. (1994) · Cited by 2,655
Research works printed but not linked: 15
- Torgerson DJ, Dolan P. The cost of treating osteoporotic fractures in the United Kingdom female population -the author replies. Osteoporos Int 2000;11:551-2.
- Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delams P, et al. Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 2005;20:1185-94.
- Duggan P, Cashman KD, Flynn A, Bolton-Smith C, Kiely M. Phylloquinone (vitamin K-1) intakes and food sources in 18-year-old to 64-year-old Irish adults. Br J Nutr 2004;92:151-8.
- Compston JE. Boning up on vitamin K - commentary. Gut 2001;48:448.
- Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review [erratum appears in JAMA 2002;288:1720]. JAMA 2002;287:3116-26.
- Cambridge Laboratories. Menadiol diphosphate tablets 10mg. 2002. URL: http://emc.medicines.org.uk/.
- National Osteoporosis Foundation Working Group on Vertebral Fractures. Assessing vertebral fractures. J Bone Miner Res 1995;10:518-523.
- Genant HK, Jergas M. Assessment of prevalent and incident fractures in osteoporosis research. Osteoporos Int 2003;14:S43-S55.
- Cranney A, Tugwell P, Wells G, Guyatt G. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocr Rev 2002;23:497-507.
- Insull W, Troendle A, Silvers A, Dunne CW. Substantial non-compliance to dose and time prescriptions for medications treating hypercholesterolaemia. Atherosclerosis 1995;115:S93.
- Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993;269:2779-81.
- Howell N, Trotter R, Mottram DR, Rowe PH. Compliance with statins in primary care. Pharm J 2004;272:23-6.
- Cochrane Review Manager 4.2.7. Oxford: The Cochrane Collaboration; 2004. URL: http://ims. cochrane.org/revman/.
- Shiraki M. Vitamin K2 effects on the risk of fractures and on lumbar bone mineral density in osteoporosis -a randomized prospective open-label 3-year study. Osteoporos Int 2002;13:S160.
- Eisai Co. Ltd. Eisai announces the intermediate analysis of anti-osteoporosis treatment post-marketing research to investigate the benefits of menatetrenone as part of the Ministry of Health, Labour and Welfare's Pharmacoepidemiological Drug Review Program. 2005. URL: www.eisai.co.jp/enews/.
Cited by
Fihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000095 · Cited by 1,029
Gribble, P. A., Bleakley, C. M., Caulfield, B. M., Docherty, C. L., Fourchet, F., Fong, D. T.-P., Hertel, J., Hiller, C. E., Kaminski, T. W., McKeon, P. O., et al. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096189 · Cited by 690
Doherty, C., Bleakley, C., Delahunt, E., & Holden, S. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096178 · Cited by 408
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
Tan, D. H. S., Hull, M. W., Yoong, D., Tremblay, C., O’Byrne, P., Thomas, R., Kille, J., Baril, J.-G., Cox, J., Giguere, P., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170494 · Cited by 220
O'Doherty, L. J., Taft, A., Hegarty, K., Ramsay, J., Davidson, L. L., & Feder, G. (2014) · BMJ · doi:10.1136/bmj.g2913 · Cited by 202
Herman, P. M., Poindexter, B. L., Witt, C. M., & Eisenberg, D. M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001046 · Cited by 185
Cost-Effectiveness of Spinal Cord Stimulation Therapy in Management of Chronic Pain
Kumar, K., & Rizvi, S. (2013) · Pain Medicine · doi:10.1111/pme.12146 · Cited by 175
Klassen, A. F., Riff, K. W. Y. W., Longmire, N. M., Albert, A., Allen, G., Aydın, M., Baker, S. B., Cano, S., Chan, A. J., Courtemanche, D. J., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170289 · Cited by 162
Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods
Jackson, C. H., Stevens, J., Ren, S., Latimer, N. R., Bojke, L., Manca, A., & Sharples, L. D. (2016) · Medical Decision Making · doi:10.1177/0272989x16639900 · Cited by 144
Systematic review and statistical analysis of the integrity of 33 randomized controlled trials
Bolland, M. J., Avenell, A., Gamble, G. D., & Grey, A. (2016) · Neurology · doi:10.1212/wnl.0000000000003387 · Cited by 106
Huang, Z.-L., Wan, S., Lu, Y.-J., Ning, L., Liu, C., & Fan, S. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2989-6 · Cited by 116
Khalifeh, H., Oram, S., Trevillion, K., Johnson, S., & Howard, L. M. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.144899 · Cited by 104
Quinnell, T. G., Bennett, M., Jordan, J., Clutterbuck-James, A. L., Davies, M. G., Smith, I. E., Oscroft, N., Pittman, M. A., Cameron, M., Chadwick, R., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205464 · Cited by 97
Beau-Lejdstrom, R., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010508 · Cited by 83
Manchanda, R., Legood, R., Antoniou, A. C., Gordeev, V. S., & Menon, U. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103800 · Cited by 79
Stevenson, M., Lloyd-Jones, M., Morgan, M., & Wong, R. (2012) · Health Technology Assessment · doi:10.3310/hta16040 · Cited by 76
Self-citationUS Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K
Marles, R. J., Roe, A. L., & Oketch‐Rabah, H. A. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux022 · Cited by 82
Carroll, C., Stevenson, M., Scope, A., Evans, P., & Buckley, S. C. (2011) · Health Technology Assessment · doi:10.3310/hta15360 · Cited by 80
Self-citationAaseth, J., Finnes, T. E., Askim, M., & Alexander, J. (2024) · Nutrients · doi:10.3390/nu16152420 · Cited by 85
“…importance for the synthesis carboxylation of several vitamin K-dependent coagulation factors, while K2 play a more important role in peripheral tissues with a beneficial effect on skeletal In particular, vitamin K2 (Figure 1) has been found to be involved in bone remodeling and bone health [23,24].”
BackgroundIslam, Z., Ford, T., Kramer, T., Paul, M., Parsons, H., Harley, K., Weaver, T., McLaren, S., & Singh, S. P. (2016) · BJPsych Bulletin · doi:10.1192/pb.bp.115.050690 · Cited by 68
Postnatal women's experiences of management of depressive symptoms: a qualitative study
Slade, P., Morrell, C. J., Rigby, A., Ricci, K., Spittlehouse, J., & Brugha, T. S. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x532611 · Cited by 67
Lamers, I., Cattaneo, D., Chen, C. C., Bertoni, R., Wijmeersch, B. V., & Feys, P. (2014) · Physical Therapy · doi:10.2522/ptj.20130588 · Cited by 68
Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study
Booth, J. L., Mullen, A. B., Thomson, D., Johnstone, C., Galbraith, S. J., Bryson, S. M., & McGovern, E. M. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x665206 · Cited by 65
Brison, R. J., Day, A. G., Pelland, L., Pickett, W., Johnson, A. P., Aiken, A. B., Pichora, D. R., & Brouwer, B. J. (2016) · BMJ · doi:10.1136/bmj.i5650 · Cited by 69
Ma, M.-L., Ma, Z.-J., He, Y.-L., Sun, H. X., Yang, B., Ruan, B., Zhan, W.-D., Li, S.-X., Dong, H., & Wang, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.979649 · Cited by 80
Role of vitamins beyond vitamin D 3 in bone health and osteoporosis (Review)
Skalny, A. V., Aschner, M., Tsatsakis, A. M., da Rocha, J. B. T., Santamaría, A., Spandidos, D. A., Martins, A. C., Lu, R., Korobeinikova, T., Chen, W. L., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5333 · Cited by 77
“VK has been shown to be a cost‑effective strategy for preventing fractures in older women (70).”
BackgroundRasch Analysis Supports the Use of the Pain Self-Efficacy Questionnaire
Di Pietro, F., Catley, M. J., McAuley, J. H., Parkitny, L., Maher, C. G., Costa, L. D. C. M., Macedo, L. G., Williams, C. M., & Moseley, G. L. (2014) · Physical Therapy · doi:10.2522/ptj.20130217 · Cited by 56
Je, S. H., Joo, N., Choi, B. H., Kim, K., Kim, B.-T., Park, S.-B., Cho, D., Kim, K.-N., & Lee, D. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.8.1093 · Cited by 59
“Vitamin K supplementation provided protection against fractures, age related BMD decline, and osteoporosis in some studies (7-9), while other studies do not support a BMD benefit of vitamin K supplementation (10-14).”
ResultTorbergsen, A. C., Watne, L. O., Wyller, T. B., Frihagen, F., Strømsøe, K., Bøhmer, T., & Mowé, M. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.01.016 · Cited by 52
Approach to tinnitus management.
Wu, V., Cooke, B., Eitutis, S. T., Simpson, M. T. W., & Beyea, J. A. (2018) · Europe PMC (PubMed Central) · Cited by 67
Ethnicity and the diagnosis gap in liver disease: a population-based study
Alazawi, W., Mathur, R., Abeysekera, K., Hull, S., Boomla, K., Robson, J., & Foster, G. R. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682273 · Cited by 49
Abele, T. A., Besachio, D. A., Quigley, E. P., Gurgel, R. K., Shelton, C., Harnsberger, H. R., & Wiggins, R. H. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4041 · Cited by 49
Leydon, G., Turner, S., Smith, H. E., Little, P. S., & on behalf of the UTIS team (2009) · British Journal of General Practice · doi:10.3399/bjgp09x453459 · Cited by 44
Organ donation: opting in or opting out?
Rudge, C. J. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x694445 · Cited by 39
Moore, M. V., Ali, S., Stuart, B. L., Leydon, G., Ovens, J., Goodall, C., & Kendrick, T. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x649151 · Cited by 45
Vitamin K and musculoskeletal health in postmenopausal women
Hamidi, M. S., & Cheung, A. M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300950 · Cited by 39
“However, incidences of skin and skin appendage lesions have been reported with the use of 45 mg/day of MK-4 supplements [21].”
BackgroundYield of CT Angiography and Contrast-Enhanced MR Imaging in Patients with Dizziness
Fakhran, S., Alhilali, L. M., & Branstetter, B. F. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3325 · Cited by 36
Nshimyumukiza, L., Durand, A., Gagnon, M., Douville, X., Morin, S. N., Lindsay, C., Duplantie, J., Gagné, C., Jean, S., Giguère, Y., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1758 · Cited by 33
Raising the bar for using surrogate endpoints in drug regulation and health technology assessment
Dawoud, D., Naci, H., Ciani, O., & Bujkiewicz, S. (2021) · BMJ · doi:10.1136/bmj.n2191 · Cited by 48
Update on nutrients involved in maintaining healthy bone
Rondanelli, M., Opizzi, A., Perna, S., & Faliva, M. A. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.09.006 · Cited by 34
“The evidence summarized in a meta-analysis confirms the results of ECKO trial and suggests that phylloquinone is associated with a significant reduction in the risk of clinical fractures in postmenopausal women with osteopenia, but without osteoporosis.(36) Remarkably, throughout the literature the association between…”
ResultSu, S., He, N., Men, P., Song, C., & Zhai, S. (2019) · Osteoporosis International · doi:10.1007/s00198-019-04853-7 · Cited by 34
“Unlike previous studies [12, 13, 16], we included trials without patient age or sex limitations per the indication of menatetrenone.”
ResultNew developments in the treatment of osteoporosis
Eriksen, E. F., Halse, J., & Moen, M. H. (2012) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01473.x · Cited by 35
Tanaka, S., Miyazaki, T., Uemura, Y., Miyakawa, N., Gorai, I., Nakamura, T., Fukunaga, M., Ohashi, Y., Ohta, H., Mori, S., et al. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0768-5 · Cited by 30
How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis
Bojke, L., Manca, A., Asaria, M., Mahon, R., Ren, S., & Palmer, S. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0512-6 · Cited by 31
McLernon, D. J., Donnan, P. T., Sullivan, F., Roderick, P. J., Rosenberg, W. M., Ryder, S. D., & Dillon, J. F. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004837 · Cited by 34
Horyniak, D., Degenhardt, L. J., Smit, D. V., Munir, V. L., Johnston, J., FRY, C. L., & Dietze, P. (2013) · Emergency Medicine Journal · doi:10.1136/emermed-2012-202174 · Cited by 34
Results of Observational Studies: Analysis of Findings from the Nurses’ Health Study
Tai, V., Grey, A. B., & Bolland, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110403 · Cited by 28
“7 N/A 2009 [64] V: Vitamin K2 supplements (0.”
Recent advances in vitamin K-dependent Gla-containing proteins and vitamin K nutrition
Shiraki, M., Tsugawa, N., & Okano, T. (2015) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2015.07.009 · Cited by 31
Kendrick, T., Stuart, B. L., Leydon, G., Geraghty, A. W. A., Yao, L., Dewar-Haggart, R., Williams, S. J., Zhu, S., Dowrick, C. F., Lewis, G., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015266 · Cited by 29
Hirst, A., Knight, C., Hirst, M., Dunlop, W., & Akehurst, R. L. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-015-0673-1 · Cited by 24
“Hip fracture in the elderly, in particular, is associated with increased mortality risk [22].”
BackgroundTorbergsen, A. C., Watne, L. O., Frihagen, F., Wyller, T. B., & Mowé, M. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2017.11.012 · Cited by 20
Vitamin K and Bone Health in Older Adults
Shah, K. N., Gleason, L. J., & Villareal, D. T. (2014) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2014.875818 · Cited by 20
“The supplementation with either MK-4 or MK-7 results in similar carboxylation of osteocalcin (17), however ML-7 has a longer halflife than MK-4 or phylloquinone and therefore it may be more effective as a low-dose supplement (18).”
BackgroundMulla, S. M., Buckley, D. N., Moulin, D. E., Couban, R., Izhar, Z., Agarwal, A., Panju, A. A., Wang, L., Makosso‐Kallyth, S., Turan, A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006112 · Cited by 21
Ride, J., Lorgelly, P. K., Tran, T. D., Wynter, K. H., Rowe, H. J., & Fisher, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012086 · Cited by 25
Responding to intimate partner and sexual violence against women
Sohal, A. H., & James-Hanman, D. (2013) · BMJ · doi:10.1136/bmj.f3100 · Cited by 20
USE OF VALUE OF INFORMATION IN UK HEALTH TECHNOLOGY ASSESSMENTS
Mohiuddin, S., Fenwick, E. A. L., & Payne, K. (2014) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462314000701 · Cited by 18
“Stevenson et al (37) 2009 EVSI 10 years Not reported 50,000 Not applicable Not applicable Not applicable Yes Stevenson et al (38) 2010 EVPI EVPPI 10 years Not reported 1,200,000 £53.”
BackgroundMethodInfluentialRobson, J. P., Smithers, H., Chowdhury, T. A., Bennett-Richards, P., Keene, D., Dostal, I., Mathur, R., Dunne, J., Hull, S., & Boomla, K. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x684421 · Cited by 18
Krakow, B. J., Ulibarri, V. A., Foley-Shea, M. R., Tidler, A., & McIver, N. D. (2016) · Respiratory Care · doi:10.4187/respcare.04538 · Cited by 14
Jones, G., Winzenberg, T. M., Callisaya, M. L., & Laslett, L. L. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.07.004 · Cited by 19
Stevenson, M., & Jones, M. L. (2010) · Medical Decision Making · doi:10.1177/0272989x10364848 · Cited by 18
“The revised model, together with the calibration against the former model, is provided elsewhere.(9) Two cohorts are simulated: one receiving alendronate treatment for 5 y, and the 2nd receiving vitamin K1 for 5 y.”
BackgroundMethodResultSelf-citationLittle, P. S., Stuart, B. L., Wingrove, Z., Mullee, M., Thomas, T., Johnson, S., Leydon, G., Richards-Hall, S., Williamson, I. G., Yao, L., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170599 · Cited by 13
Lawson, K. D., Lewsey, J., Ford, I., Fox, K. A. A., Ritchie, L. D., Tunstall-Pedoe, H., Watt, G. C. M., Woodward, M., Kent, S., Neilson, M., et al. (2016) · Open Heart · doi:10.1136/openhrt-2014-000140 · Cited by 13
Gajic‐Veljanoski, O., Bayoumi, A. M., TOMLINSON, G. A., Khan, K., & Cheung, A. M. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1939-4 · Cited by 16
“They compared 5 mg/ day vitamin K1 to no intervention in 50-year-old women with osteoporosis over 10 years [54].”
MethodInfluentialModelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to Consider
Stevenson, M., & Selby, P. L. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0156-8 · Cited by 13
“[8] where, adjusting only for age and previous fracture, it was estimated that the risks of hip fracture for women aged 70–74 years, with average BMD and no fracture, were 54 % lower than those for the average of women aged 70–74 years.”
BackgroundSelf-citationWong, J. B., Coates, P. M., Russell, R. M., Dwyer, J. T., Schuttinga, J. A., Bowman, B. A., & Peterson, S. A. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00412.x · Cited by 13
Asymmetric hearing loss and tinnitus
Kontorinis, G., & CROWTHER, J. A. (2014) · BMJ · doi:10.1136/bmj.g3601 · Cited by 9
RETRACTED ARTICLE: Menatetrenone for the treatment of osteoporosis
Iwamoto, J., & Satō, Y. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.763796 · Cited by 10
“A meta-analysis study [28], but not a systematic review study [29], showed efficacy against vertebral and nonvertebral fractures mainly in postmenopausal women with osteoporosis (Table 4).”
BackgroundInfluentialRetractedGeneralised anxiety disorder: the importance of life context and social factors
Tait, L., & Berrisford, G. S. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x572625 · Cited by 8
Tanaka, S., Miyazaki, T., Uemura, Y., Kuroda, T., Miyakawa, N., Nakamura, T., Fukunaga, M., Ohashi, Y., Ohta, H., Mori, S., et al. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0491-4 · Cited by 7
“Although a meta-analysis indicated a potential effect of vitamin K administration on fracture prevention [14], little effort has been paid to promoting the importance of vitamin K repletion in the prevention of osteoporotic fractures.”
BackgroundPrescribing antidepressants for depression: time to be dimensional and inclusive
Anderson, I. M., & Haddad, P. M. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x548992 · Cited by 5
Kaneyasu, Y., Fujiwara, H., Akita, T., Tanaka, J., Shibata, Y., Nakagawa, T., Koh, I., Hirata, E., Hyodo, M., Miyamoto, T., et al. (2025) · Japanese Journal of Radiology · doi:10.1007/s11604-025-01733-5 · Cited by 4
“Stevenson reported that there are no adverse events as associated with vitamin K use [33].”
The Elderly Inflammatory Bowel Disease Patient and Osteoporosis
Katz, S., & Weinerman, S. A. (2012) · Aging Health · doi:10.2217/ahe.11.86 · Cited by 4
Youn, J.-H., Stevenson, M., Thokala, P., Payne, K., & Goddard, M. K. (2019) · Medical Decision Making · doi:10.1177/0272989x19868987 · Cited by 5
“The economic model produced by Stevenson et al.21 was used as a basis for the osteoporosis model constructed for the case study (see Figure 3c).”
BackgroundMethodInfluentialSelf-citationÖzgen, M., Coşan, D. T., Doğaner, F., Soyocak, A., Armağan, O., Kuzgun, S., Çıracıoğlu, A. M., Güneş, H. V., Değirmenci, İ., & Mutlu, F. (2019) · Clinics · doi:10.6061/clinics/2019/e739 · Cited by 3
“Many reports on vitamin K treatment in osteoporosis and related fractures have been published (7,14-16).”
BackgroundRole of Nutrition in the Management of Patients with Multiple Endocrine Neoplasia Type 1
Marinari, M., Marini, F., Giusti, F., & Brandi, M. L. (2024) · Nutrients · doi:10.3390/nu16111576 · Cited by 4
“Furthermore, there is a consistent line of evidence in epidemiological and human intervention studies demonstrating that vitamin K can not only increase BMD in osteoporotic individuals, but also reduce fragility fracture rate [34,35].”
ResultThompson, M. M., Niemuth, A., Sabbatini, J., Levin, D., Breeze, M. L., Li, X., Perez, T., Taylor, M. L., & Harrigan, G. G. (2016) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-016-2795-8 · Cited by 2
Cost‐Effectiveness of Osteoporosis Treatment
Tosteson, A. N. A. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch55 · Cited by 2
Cost-Effectiveness of Osteoporosis Treatment
Moriwaki, K. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_31 · Cited by 1
(EFSA), E. F. S. A. (2015) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2015.en-812 · Cited by 1
Osteoporosis: Complementary and Integrative Approaches
Lucius, K. (2024) · Integrative and Complementary Therapies · doi:10.1089/ict.2024.39337.kl · Cited by 2
Vitamin K and hip fractures: what do we know?
Marks, R. (2022) · MOJ Gerontology & Geriatrics · doi:10.15406/mojgg.2022.07.00286 · Cited by 1
Cost‐Effectiveness of Osteoporosis Treatment
Tosteson, A. N. A. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch79 · Cited by 1
Mahon, R. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 6
CLINICAL EVIDENTIAL AND METHODOLOGICAL CHALLENGES OF EARLY ASSESSMENTS OF NEW HEALTH TECHNOLOGIES
Dequen, P. (2016) · Figshare
Kitanova, M., Popov, H. I., Gancheva, S., Zhelyazkova-Savova, M., Galunska, B. T., & Ghenev, P. (2016) · Trakia Journal of Sciences · doi:10.15547/tjs.2016.04.008
Prise en charge de l’acouphène
Wu, V., Cooke, B., Eitutis, S. T., Simpson, M. T. W., & Beyea, J. A. (2018) · Europe PMC (PubMed Central) · Cited by 1
Bone metabolism in inflammatory bowel diseases 1
Kupka, T., Svoboda, P., Bojková, M., Blaho, M., Vašura, A., Hrabovský, V., & Dítě, P. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.131
“Existuje několik prospektivních studií vlivu suplementace vitaminu K na kostní denzitě (BMD) nebo riziku zlomenin (52), ale neexistují žádné publikované kontrolované studie u pacientů s IBD.”
Theiler‐Schwetz, V., Riedmann, U., Zelzer, S., Meinitzer, A., Schmitt, L., Kraus, D. A., Trummer, C., Gruebler, M. R., Keppel, M. H., Zittermann, A., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1857443
Metadata
- Authors
- Stevenson, M., Lloyd-Jones, M., & Papaioannou, D.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Stevenson, M
- Venue
- Health Technology Assessment
- Published
- 2009-09
- Volume
- 13
- Issue
- 45
- Pages
- iii-xi, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2158674987
- Cited by
- 90
- References
- 275
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 15 · 2015: 6 · 2014: 18 · 2013: 8 · 2012: 9
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health Technology Assessment programme (07/16/01)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin K, osteoporotic fractures, postmenopausal women, vitamin K1, menatetrenone, fracture prevention, cost-effectiveness, vertebral fractures, non-vertebral fractures, osteopenia, osteoporosis, adverse events, economic evaluation model
- MeSH terms
- Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Humans, Vitamin K 1, Vitamin K, Vitamins, Osteoporosis, Postmenopausal, Models, Econometric, Quality-Adjusted Life Years, Vitamin K 2, Bone Density Conservation Agents, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.